Pulmonary Drug Delivery Devices Market (Product Type: Dry Powder Inhalers, Metered Dose Inhalers, and Nebulizers; Application: Asthma, COPD, and Cystic Fibrosis) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Pulmonary Drug Delivery Devices Market (Product Type: Dry Powder Inhalers, Metered Dose Inhalers, and Nebulizers; Application: Asthma, COPD, and Cystic Fibrosis) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Pulmonary Drug Delivery Devices Market – Scope of Report

TMR’s report on the global pulmonary drug delivery devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global pulmonary drug delivery devices market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pulmonary drug delivery devices market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the pulmonary drug delivery devices market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global pulmonary drug delivery devices market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global pulmonary drug delivery devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global pulmonary drug delivery devices market.

The report delves into the competitive landscape of the global pulmonary drug delivery devices market. Key players operating in the global pulmonary drug delivery devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global pulmonary drug delivery devices market profiled in this report.

Key Questions Answered in Global pulmonary drug delivery devices Market Report
  • What is the sales/revenue generated by pulmonary drug delivery devices across all regions during the forecast period?
  • What are the opportunities in the global pulmonary drug delivery devices market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Pulmonary Drug Delivery Devices Market – Research Objectives and Research Approach

The comprehensive report on the global pulmonary drug delivery devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global pulmonary drug delivery devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global pulmonary drug delivery devices market.


1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pulmonary Drug Delivery Devices Market
4. Market Overview
4.1. Market Segmentation
  4.1.1. Segment Definition
  4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
  4.3.1. Drivers
  4.3.2. Restraints
  4.3.3. Opportunities
4.4. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, 2023-2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
5.3. COVID-19 Pandemic Impact on Industry
6. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value & Volume Forecast, by Product Type, 2023-2031
  6.3.1. Dry Powder Inhalers
  6.3.2. Metered Dose Inhalers
  6.3.3. Nebulizers
6.4. Market Attractiveness, by Product Type
7. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Application
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value & Volume Forecast, by Application, 2023-2031
  7.3.1. Asthma
  7.3.2. COPD
  7.3.3. Cystic Fibrosis
  7.3.4. Others
7.4. Market Attractiveness, by Application
8. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Distribution Channel
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
  8.3.1. Retail Pharmacies
  8.3.2. Hospital Pharmacies
  8.3.3. E-Commerce
8.4. Market Attractiveness, by Distribution Channel
9. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value & Volume Forecast, by Region, 2023-2031
  9.2.1. North America
  9.2.2. Europe
  9.2.3. Asia Pacific
  9.2.4. Latin America
  9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Pulmonary Drug Delivery Devices Market Analysis and Forecast
10.1. Introduction
  10.1.1. Key Findings
10.2. Market Value & Volume Forecast, by Product Type, 2023-2031
  10.2.1. Dry Powder Inhalers
  10.2.2. Metered Dose Inhalers
  10.2.3. Nebulizers
10.3. Market Attractiveness, by Product Type
10.4. Market Value & Volume Forecast, by Application, 2023-2031
  10.4.1. Asthma
  10.4.2. COPD
  10.4.3. Cystic Fibrosis
  10.4.4. Others
10.5. Market Attractiveness, by Application
10.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
  10.6.1. Retail Pharmacies
  10.6.2. Hospital Pharmacies
  10.6.3. E-Commerce
10.7. Market Attractiveness, by Distribution Channel
10.8. Market Value & Volume Forecast, by Country, 2023-2031
  10.8.1. U.S.
  10.8.2. Canada
10.9. Market Attractiveness Analysis
  10.9.1. By Product Type
  10.9.2. By Application
  10.9.3. By Distribution Channel
  10.9.4. By Country
11. Europe Pulmonary Drug Delivery Devices Market Analysis and Forecast
11.1. Introduction
  11.1.1. Key Findings
11.2. Market Value & Volume Forecast, by Product Type, 2023-2031
  11.2.1. Dry Powder Inhalers
  11.2.2. Metered Dose Inhalers
  11.2.3. Nebulizers
11.3. Market Attractiveness, by Product Type
11.4. Market Value & Volume Forecast, by Application, 2023-2031
  11.4.1. Asthma
  11.4.2. COPD
  11.4.3. Cystic Fibrosis
  11.4.4. Others
11.5. Market Attractiveness, by Application
11.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
  11.6.1. Retail Pharmacies
  11.6.2. Hospital Pharmacies
  11.6.3. E-Commerce
11.7. Market Attractiveness, by Distribution Channel
11.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
  11.8.1. Germany
  11.8.2. U.K.
  11.8.3. France
  11.8.4. Italy
  11.8.5. Spain
  11.8.6. Rest of Europe
11.9. Market Attractiveness Analysis
  11.9.1. By Product Type
  11.9.2. By Application
  11.9.3. By Distribution Channel
  11.9.4. By Country/Sub-region
12. Asia Pacific Pulmonary Drug Delivery Devices Market Analysis and Forecast
12.1. Introduction
  12.1.1. Key Findings
12.2. Market Value & Volume Forecast, by Product Type, 2023-2031
  12.2.1. Dry Powder Inhalers
  12.2.2. Metered Dose Inhalers
  12.2.3. Nebulizers
12.3. Market Attractiveness, by Product Type
12.4. Market Value & Volume Forecast, by Application, 2023-2031
  12.4.1. Asthma
  12.4.2. COPD
  12.4.3. Cystic Fibrosis
  12.4.4. Others
12.5. Market Attractiveness, by Application
12.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
  12.6.1. Retail Pharmacies
  12.6.2. Hospital Pharmacies
  12.6.3. E-Commerce
12.7. Market Attractiveness, by Distribution Channel
12.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
  12.8.1. China
  12.8.2. Japan
  12.8.3. India
  12.8.4. Australia & New Zealand
  12.8.5. Rest of Asia Pacific
12.9. Market Attractiveness Analysis
  12.9.1. By Product Type
  12.9.2. By Application
  12.9.3. By Distribution Channel
  12.9.4. By Country/Sub-region
13. Latin America Pulmonary Drug Delivery Devices Market Analysis and Forecast
13.1. Introduction
  13.1.1. Key Findings
13.2. Market Value & Volume Forecast, by Product Type, 2023-2031
  13.2.1. Dry Powder Inhalers
  13.2.2. Metered Dose Inhalers
  13.2.3. Nebulizers
13.3. Market Attractiveness, by Product Type
13.4. Market Value & Volume Forecast, by Application, 2023-2031
  13.4.1. Asthma
  13.4.2. COPD
  13.4.3. Cystic Fibrosis
  13.4.4. Others
13.5. Market Attractiveness, by Application
13.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
  13.6.1. Retail Pharmacies
  13.6.2. Hospital Pharmacies
  13.6.3. E-Commerce
13.7. Market Attractiveness, by Distribution Channel
13.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
  13.8.1. Brazil
  13.8.2. Mexico
  13.8.3. Rest of Latin America
13.9. Market Attractiveness Analysis
  13.9.1. By Product Type
  13.9.2. By Application
  13.9.3. By Distribution Channel
  13.9.4. By Country/Sub-region
14. Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis and Forecast
14.1. Introduction
  14.1.1. Key Findings
14.2. Market Value & Volume Forecast, by Product Type, 2023-2031
  14.2.1. Dry Powder Inhalers
  14.2.2. Metered Dose Inhalers
  14.2.3. Nebulizers
14.3. Market Attractiveness, by Product Type
14.4. Market Value & Volume Forecast, by Application, 2023-2031
  14.4.1. Asthma
  14.4.2. COPD
  14.4.3. Cystic Fibrosis
  14.4.4. Others
14.5. Market Attractiveness, by Application
14.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031
  14.6.1. Retail Pharmacies
  14.6.2. Hospital Pharmacies
  14.6.3. E-Commerce
14.7. Market Attractiveness, by Distribution Channel
14.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031
  14.8.1. GCC Countries
  14.8.2. South Africa
  14.8.3. Rest of Middle East & Africa
14.9. Market Attractiveness Analysis
  14.9.1. By Product Type
  14.9.2. By Application
  14.9.3. By Distribution Channel
  14.9.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
  15.3.1. AstraZeneca Plc
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Type Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
  15.3.2. Novartis AG
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Type Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
  15.3.3. Boehringer Ingelheim GmbH
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Type Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
  15.3.4. GlaxoSmithKline Plc
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Type Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
  15.3.5. Merck & Co., Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Type Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
  15.3.6. Teva Pharmaceutical Industries Ltd.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Type Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings